Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01836 |
| Species: | Homo sapiens |
| Position : | chr6:45407433-45444666 |
| Year: | 2024 |
| Title: | Exploring the transcriptional cooperation between RUNX2 and its associated elncRNA RAIN. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | thyroid gland carcinoma |
| PMID: | 39271656 |
| MONDO: | MONDO:0015075 |
| Tissue: | thyroid gland |
| Tissue Ontology ID: | UBERON:0002046 |
| Cell Source: | TPC-1 |
| CVCL ID: | CVCL_6298 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | RNA-chromatin association assay; Functional perturbation assay; In vivo functional validation |
| High Throughput Method: | ChIRP-seq; RNA-seq; H3K4me1/H3K4me3/H3K27ac ChIP-seq |
| Low Throughput Method: | qRT-PCR; RAIN CRISPRi; Western blot; In vivo phenotyping |
| Target gene : | RUNX2 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01809 | chr6:45407433-45444666 | thyroid gland | malignant cell | thyroid gland carcinoma |